hat
Kesyon prensipal la, sepandan, se; ki jan li travay? Pa gen yon konklizyon eksplisit sou mekanis ke medikaman sa a itilize pou bay rezilta yo. Men, chèchè yo te vini ak yon teyori, swiv lefèt ke serotonin se responsab pou anpeche fonksyon seksyèl, epi yo te jwenn ke Flibanserin (167933-07-5) diminye aktivite serotonin nan sèvo a. Sa a, an retou, retabli dezi seksyèl fanm lan. Epitou, medikaman an gen kèk enpak endirèk sou noradrenalin ak dopamine, ki yo tou ki konekte ak amelyore dezi seksyèl.
eng
The main question, however, is; how does it work? There has not been an explicit finding on the mechanism used by this medication to yield results. Yet, researchers have come up with a theory, following the fact that serotonin is liable for inhibiting sexual function, and they have found that Flibanserin (167933-07-5) reduces serotonin activity in the brain. This, in return, restores the woman’s sexual desire. Also, the medication has some indirect impact on norepinephrine and dopamine, which are also connected to enhanced sexual desires.